WHO Model Prescribing Information: Drugs Used in Anaesthesia
(1989; 60 pages) [French] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuPremedication
Ouvrir ce répertoire et afficher son contenuGeneral anaesthetics and oxygen
Ouvrir ce répertoire et afficher son contenuLocal anaesthetics
Ouvrir ce répertoire et afficher son contenuNon-opioid analgesics
Ouvrir ce répertoire et afficher son contenuOpioid analgesics and antagonists
Ouvrir ce répertoire et afficher son contenuMuscle relaxants and cholinesterase inhibitors
Ouvrir ce répertoire et afficher son contenuBlood substitutes
Fermer ce répertoireSolutions for correcting water and electrolyte imbalance
Afficher le documentCompound solution of sodium lactate
Afficher le documentGlucose
Afficher le documentGlucose with sodium chloride
Afficher le documentSodium chloride
Afficher le documentPotassium chloride
Ouvrir ce répertoire et afficher son contenuAntacid for use in obstetric practice
Afficher le documentAnaesthesia at the District Hospital
Afficher le documentSelected WHO publications of related interest
Afficher le documentBack cover
 

Glucose

Group: intravenous infusion fluid
Injectable isotonic solution: 50 mg/ml (5%)

Clinical information

Uses

• Postoperative fluid replacement in patients with no sodium deficit, until adequate fluid can be taken by mouth.

• Intravenous rehydration of patients suffering from water depletion for whom oral rehydration salts are not suitable.

Dosage and administration

Individual requirements should always be determined on the basis of clinical and, whenever possible, electrolyte monitoring.

Precautions

Patients must be monitored for signs of intravascular overload. In this event infusion must be slowed or suspended and, if necessary, a rapidly acting diuretic administered (for example furosemide 40 mg i.v.).

Patients with overt or known diabetes additionally require insulin and close biochemical monitoring.

Prolonged parenteral infusion of glucose solutions may inhibit secretion of insulin. To minimize the risk of hyperglycaemia it may be necessary to add insulin to the infusion.

Adverse effects

Infusion of large volumes of glucose solution may cause hyponatraemia.

Unduly rapid replacement may lead to pulmonary oedema.

Storage

Glucose solution should be kept in sealed containers.

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018